|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
51957799
線上人數 :
952
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"wen yih w u"的相關文件
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-03-03T03:00:49Z |
Comparisons of the Clinical Outcomes and Urodynamic Effects of Mirabegron versus Tolterodine Treatment for Female Overactive Bladder Syndrome: A Subgroup Analysis of a Controlled, Randomised, Prospective Study
|
Hsiao S.-M.;Chang T.-C.;Chen C.-H.;Wen-Yih W.U.;Ho-Hsiung Lin; Hsiao S.-M.; Chang T.-C.; Chen C.-H.; Wen-Yih W.U.; HO-HSIUNG LIN |
| 臺大學術典藏 |
2020-02-17T08:50:49Z |
Comparisons of the Clinical Outcomes and Urodynamic Effects of Mirabegron versus Tolterodine Treatment for Female Overactive Bladder Syndrome: A Subgroup Analysis of a Controlled, Randomised, Prospective Study
|
HO-HSIUNG LIN; Hsiao S.-M; Chang T.-C; Chen C.-H; Wen-Yih W.U |
| 臺大學術典藏 |
2020-02-17T05:28:06Z |
Comparisons of the Clinical Outcomes and Urodynamic Effects of Mirabegron versus Tolterodine Treatment for Female Overactive Bladder Syndrome: A Subgroup Analysis of a Controlled, Randomised, Prospective Study
|
Hsiao S.-M;Ting-Chen Chang;Chen C.-H;Wen-Yih W.U;Lin H.-H.; Hsiao S.-M; TING-CHEN CHANG; Chen C.-H; Wen-Yih W.U; Lin H.-H. |
| 臺大學術典藏 |
2020-02-17T05:28:06Z |
Comparisons of the Clinical Outcomes and Urodynamic Effects of Mirabegron versus Tolterodine Treatment for Female Overactive Bladder Syndrome: A Subgroup Analysis of a Controlled, Randomised, Prospective Study
|
Hsiao S.-M;Ting-Chen Chang;Chen C.-H;Wen-Yih W.U;Lin H.-H.; Hsiao S.-M; TING-CHEN CHANG; Chen C.-H; Wen-Yih W.U; Lin H.-H. |
| 臺大學術典藏 |
2020-01-22T08:53:02Z |
Comparisons of the Clinical Outcomes and Urodynamic Effects of Mirabegron versus Tolterodine Treatment for Female Overactive Bladder Syndrome: A Subgroup Analysis of a Controlled, Randomised, Prospective Study
|
Hsiao S.-M.;Chang T.-C.;Chi-Hau Chen;Wen-Yih W.U.;Lin H.-H.; Hsiao S.-M.; Chang T.-C.; CHI-HAU CHEN; Wen-Yih W.U.; Lin H.-H. |
| 臺大學術典藏 |
2020-01-22T08:53:02Z |
Comparisons of the Clinical Outcomes and Urodynamic Effects of Mirabegron versus Tolterodine Treatment for Female Overactive Bladder Syndrome: A Subgroup Analysis of a Controlled, Randomised, Prospective Study
|
Hsiao S.-M.;Chang T.-C.;Chi-Hau Chen;Wen-Yih W.U.;Lin H.-H.; Hsiao S.-M.; Chang T.-C.; CHI-HAU CHEN; Wen-Yih W.U.; Lin H.-H. |
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
|
